Zydus receives FDA OK for ZituvioZituvio is used to treat adult patients with Type 2 diabetes mellitus. Surescripts acquires ActiveRADAR ActiveRADAR offers evidence-based, formulary-specific and medically accepted use-specific therapeutic alternatives. Alembic unveils 2 generics Alembic is launching generic Robinul and generic Adrucil. iA partners with Euclid Medical Products iA’s NEXiA Enterprise Software Suite will integrate Euclid’s Axial Adherence Packaging Technology into centralized fulfillment solutions. U.S. District Court dismisses Norwich’s lawsuit against the FDA over generic Xifaxan Norwich asked the District Court to direct the FDA in granting immediate approval for generic Xifaxan (rifaximin) 550 mg. Healing the healthcare system Empowering pharmacists to keep us healthy is critical for the industry. FDA approves Amgen’s Wezlana biosimilar Wezlana is used to treat multiple inflammatory diseases. Phathom Pharmaceuticals receives FDA nod for Voquezna Voquezna is a new treatment for adults for the healing and maintenance of all grades of erosive esophagitis. Alembic debuts 2 generics Alembic is introducing generic chlorpromazine hydrochloride tablets and generic Combigan. Pharmacy orgs laud bipartisan Senate Finance Committee vote to advance PBM reforms in Medicare, Medicaid The Senate Finance Committee advanced the legislation on a strong bipartisan vote of 26-0, with one ‘present.’ First Previous 54 55 56 57 58 Next Last
